The Combination Therapy of TACE and Ablation With Durvalumab in Hepatocellular Carcinoma at Intermediate Stage (TAD)
Clinical trial NCT04517227 · UNKNOWN
Trial details
- NCT number
- NCT04517227
- Sponsor
- Fudan University
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-01
- Primary completion
- 2025-06-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.